NCT02322736 - Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR | Biotech Hunter

Enrollment

218

Participants

Timeline

Start Date

November 21, 2014

Primary Completion Date

August 3, 2018

Study Completion Date

August 3, 2018

Conditions

Metastatic Colorectal Cancer

Trial Locations (20)

11521

Research Site, Ampelokipoi, Athens

11522

Research Site, Athens

11525

Research Site, Athens

11526

Research Site, Papagou

11527

Research Site, Athens

11528

Research Site, Athens

12462

Research Site, Athens

14564

Research Site, Athens

Research Site, Nea Kifissia, Athens

15123

Research Site, Maroussi, Athens

15562

Research Site, Athens

18537

Research Site, Piraeus

41221

Research Site, Larissa

45500

Research Site, Ioannina

54007

Research Site, Thessaloniki

54622

Research Site, Thessaloniki

55236

Research Site, Thessaloniki

56429

Research Site, Thessaloniki

71110

Research Site, Heraklion - Crete

71409

Research Site, Heraklion